Genetic/JJ
evidence/NN
for/IN
an/DT
additional/JJ
factor/NN
required/VBN
for/IN
erythropoietin-induced/JJ
signal/NN
transduction/NN
./.

Erythropoietin/NN
(/(
EPO/NN
)/)
and/CC
its/PRP$
receptor/NN
(/(
EPOR/NN
)/)
are/VBP
required/VBN
for/IN
the/DT
development/NN
of/IN
mature/JJ
erythrocytes/NNS
./.
=====
After/IN
binding/NN
of/IN
ligand/NN
,/,
the/DT
EPOR/NN
activates/VBZ
a/DT
variety/NN
of/IN
signaling/NN
pathways/NNS
that/WDT
ultimately/RB
control/VBP
cellular/JJ
proliferation/NN
,/,
survival/NN
,/,
and/CC
specific/JJ
gene/NN
expression/NN
./.
=====
Although/IN
erythroid/JJ
progenitors/NNS
appear/VBP
to/TO
be/VB
the/DT
principal/JJ
EPO-responsive/JJ
cell/NN
type/NN
in/FW
vivo/FW
due/JJ
to/TO
the/DT
restricted/JJ
expression/NN
of/IN
the/DT
EPOR/NN
,/,
many/JJ
growth/NN
factor-dependent/JJ
cell/NN
lines/NNS
expressing/VBG
the/DT
EPOR/NN
can/MD
respond/VB
to/TO
EPO/NN
by/IN
activating/VBG
many/JJ
or/CC
all/DT
of/IN
these/DT
pathways/NNS
./.
=====
In/IN
the/DT
present/JJ
study/NN
,/,
we/PRP
have/VBP
identified/VBN
a/DT
cellular/JJ
context/NN
(/(
the/DT
interleukin-2/NN
[/(
IL-2/NN
]/)
-dependent/JJ
HT-2/NN
line/NN
)/)
in/IN
which/WDT
the/DT
EPO/NN
stimulation/NN
of/IN
the/DT
EPOR/NN
fails/VBZ
to/TO
support/VB
cellular/JJ
proliferation/NN
,/,
STAT-5/NN
induction/NN
,/,
or/CC
MAPK/NN
activation/NN
,/,
despite/IN
efficient/JJ
phosphorylation/NN
of/IN
the/DT
EPOR/NN
and/CC
JAK2/NN
and/CC
inhibition/NN
of/IN
apoptosis/NN
after/IN
withdrawal/NN
of/IN
IL-2/NN
./.
=====
Interestingly/RB
,/,
when/WRB
we/PRP
fused/VBD
HT-2/NN
cells/NNS
expressing/VBG
the/DT
EPOR/NN
with/IN
Ba/F3/NN
cells/NNS
in/IN
a/DT
complementation/NN
assay/NN
,/,
the/DT
resulting/VBG
hybridomas/NN
proliferated/VBD
and/CC
potently/RB
activated/VBD
STAT-5/NN
and/CC
MAPK/NN
in/IN
response/NN
to/TO
EPO/NN
./.
=====
These/DT
data/NNS
indicate/VBP
that/IN
an/DT
unidentified/JJ
cellular/JJ
factor/NN
is/VBZ
needed/VBN
to/TO
mediate/VB
signaling/NN
by/IN
the/DT
EPOR/NN
./.
=====
Moreover/RB
,/,
Ba/F3/NN
cells/NNS
apparently/RB
express/VBP
this/DT
factor/NN
(/(
s/NNS
)/)
and/CC
somatic/JJ
fusions/NNS
can/MD
,/,
therefore/RB
,/,
confer/VB
EPO-responsiveness/NN
to/TO
HT-2/NN
cells/NNS
that/WDT
lack/VBP
this/DT
factor/NN
./.